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Aims: Increasing need for magnetic resonance imaging (MRI) has driven the 
development of MR-conditional cardiac implantable electronic devices (CIEDs -
pacemakers and defibrillators), however patients still report difficulties obtaining 
scans. We sought to establish current provision for MRI scanning of patients with 
CIEDs in England.  
Methods: A survey was distributed to all hospitals in England with MRI, to assess 
current practice.  Information requested included whether hospitals currently offer 
MRI to this patient group, the number and type of scans acquired, local safety 
considerations, complications experienced and perceived obstacles to service 
provision in those departments not currently offering it. 
Results: Responses were received from 195 of 227 (86%) of hospitals surveyed. 
Although 98% of departments were aware of MR-conditional devices, only 46% 
(n=89) currently offer MRI scans to patients with CIED’s; of these, 85% of 
departments perform ≤10 scans per year. No major complications were reported 
from MRI scanning in patients with MR-conditional devices. Current barriers to 
service expansion include perceived concerns regarding potential risk, lack of 
training, logistical difficulties and lack of cardiology support.  
Conclusion: Provision of MRI for patients with CIEDs is currently poor, despite 
increasing numbers of patients with MR-conditional devices and extremely low 
reported complication rates.  
 





Patients with ‘MR-conditional’ CIED’s report difficulties with accessing MRI 
diagnostic services. This study found that overall less than half (46%) of MRI 
departments currently offer a service for patients with MR-conditional CIED’s, and 
only 4% of departments will scan patients with non MR-conditional devices, despite 
extremely low reported complication rates. 
What’s New? 
What is already known about this subject? 
 Cardiac implantable electronic devices (CIEDs; pacemaker or defibrillator) 
have historically been an absolute contraindication to MRI.  
 The need for CIEDs and the need for MRI scans co-segregate, with many 
CIED patients having multiple co-morbidities. Device manufacturers have 
therefore developed MR-conditional CIEDs. 
 Anecdotally, patients with MR-conditional CIEDs report difficulty accessing 
MRI scans. Current provision for MRI scanning in patients with MR-
conditional CIEDs is unknown. 
What does this study add? 
 Less than half of MRI departments in England will scan patients with MR-
conditional cardiac devices – with only 1 in 7 of those centers scanning more 
than 10 patients a year. 
 Reported complication rates are extremely low. 
 Cardiology and Radiology need to work together to break down current 
barriers so that all eligible patients can benefit from MRI.  
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INTRODUCTION 
Until recently, the presence of a cardiac implantable electronic device (CIED -
pacemaker or implantable cardiac defibrillator, ICD) was considered an absolute 
contraindication to patients undergoing magnetic resonance imaging (MRI), because 
of the risk of harm.(1) There is an increasing clinical need for MRI, which is the 
imaging technique of choice across a broad range of diseases (particularly within the 
spheres of neurology, orthopaedics, oncology and cardiology). Recent national audit 
data shows CIED implantation rates of 837 per million in England for 2013-14, a 
figure that is growing rapidly.(2) The need for MRI is often high in patients with 
CIEDs - up to 75% will need an MRI scan during the lifetime of the device, and 17% 
within the first 12 months.(3)  
This has led to two developments: firstly, there has been the development of MR-
conditional CIEDs. These contain hardware and software tested and approved for 
use in an MRI setting (originally only in 1.5 Tesla MRI machines). First released in the 
EU in 2008 and subsequently FDA approved in 2011, these are rapidly being 
incorporated into clinical practice with MR-conditional CIED implantation now the 
standard of care in many centres.  At least one manufacturer has recently reported 
that the majority of their CIED sales are now from MR-conditional devices, and 
manufacturers are now releasing CIED’s that are MR conditional in 3T MRI machines 
and are relaxing their safety precautions on 1.5T MR-conditional devices, to allow 3T 
scanning. The protocol for scanning MR-conditional CIEDs is straightforward, 
however, the manufacturer and device type needs to be known and typically a 
cardiac physiologist is needed to program the device before and after the scan, with 
potential risk if this is not complied with.  
The second development is that there is now accumulating evidence particularly 
from the MagnaSafe registry that, under a fairly broad range of conditions, patients 
with non-MR conditional CIEDs, can safely undergo MRI,(4)  an approach endorsed in 
2013 by the ESC provided the risk-benefit ratio is favourable.(5)  
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Practically, a CIED MRI service requires cooperation between radiology and 
cardiology departments for the benefit of patients that are typically from another 
department (for example neurology).   Anecdotally, patients with CIEDs of all types 
are reporting access difficulties. We therefore set out to establish the current 
provision of MRI scanning for patients with both MR-conditional and also non MR-





A list of all NHS Trusts and hospitals with MRI departments within England was 
obtained from NHS England (www.nhs.uk). Contact details for the superintendent 
radiographer (lead radiologic technologist), lead radiologist for MRI or lead 
cardiologist for cardiac MRI were obtained. The survey was distributed electronically 
using an online dedicated survey software tool. 
 Data collection 
Participating departments were asked to complete a short (13 question) survey of 
closed response questions plus some limited free text answers (Appendix). 
Information was requested about overall awareness of MR-conditional CIEDs, and 
local hospital infrastructure (for example, the presence of onsite cardiac services) to 
scan. For those departments already providing a CIED MRI service, the type, number 
of scans and safety precautions taken were requested.  Departments were also 
asked to disclose whether they had the ability (in terms of infrastructure and 
protocols in place) to scan non MR-conditional CIEDs. Finally, departments not 
currently offering MRI to CIED patients were asked to provide reasons. Free text 
answers were broadly categorised according to comment themes. 
Statistics 
Data are presented as n (%). Comparisons between groups were made using Chi-
squared test. Analysis was performed using Graphpad Prism version 6 (GraphPad 




Responses were received from 201 out of 233 (86%) of hospitals surveyed, 
representing 153 out of 158 (97%) of acute NHS trusts in England. Of these 
responses, 6 submissions provided data across two hospital sites for a single trust 
therefore the results of the survey are based on 195 responses. The survey was 
completed by the superintendent radiographer (lead radiologic technologist) in 79%, 
lead MRI radiologist 9%, lead cardiologist for cardiac MRI 10% and unspecified in 2% 
of cases. 
Provision for MRI scanning CIED patients 
MR-conditional CIEDs: Although 98% of departments were aware of MR-conditional 
CIEDs, less than half (46%, 89 departments) currently provide an MRI service to this 
patient group, Figure 1.   51 out of the 89 departments (57%) offering CIED scanning 
also performed cardiac MRI studies, and such departments were more likely to 
perform thoracic studies (80% vs. 33%, p=<0.001). 7 sites performed MRI scanning in 
patients with CIEDs without onsite cardiology services.  
Overall activity levels were low, Figure 1. 6% of departments who say that they offer 
the service scanned no patients in the preceding 12 months; 76% of departments 
scanned between 1 and 10 patients, and only 3 departments scanned more than 20 
patients per year. One department currently offers scans only to patients with 
devices implanted at the same hospital site.  
Non MR-conditional CIEDs: only 4% (7 out of 195) of departments currently offer 
MRI scans to patients with non MR-conditional CIEDs in situ.  
Safety considerations  
There were a range of protocols and safety precautions in place for scanning CIED 
patients, Figure 2. The majority of departments (87%) had a formal written protocol; 
69% had a cardiologist or cardiac physiologist (able to programme the device) 
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present on site during the scan with 64% ensuring their physical presence in the MRI 
department. Although most departments monitor CIED patients’ observations during 
scanning (69% continuous ECG monitoring, 61% continuous pulse oximetry, 22% 
blood pressure monitoring), 15% of departments reported imaging patients without 
any haemodynamic monitoring.  
Reported complications from MRI in CIED patients 
MR-conditional CIEDs: There were no major complications (defined as arrhythmias 
or damage to the device requiring revision), Table 1.  Five departments experienced 
minor complications (defined as changes in the parameters of the device, requiring 
programming changes). 
Non MR-conditional CIEDs: There was one serious complication - a transient pause 
in pacing with syncope in a pacing-dependent patient, with no longer-term sequelae. 
Subsequent analysis of the print out detailing the pre-procedure programming 
changes showed that the patient had not been appropriately programmed to VOO 
mode, leading to pacing inhibition and transient asystole. 
Reasons for not scanning CIEDs 
Of the 106 departments not currently offering MRI scans to patients with MR-
conditional CIEDs, a number of different reasons were provided, Figure 3. These 
included concerns about risk, lack of evidence of safety, lack of training and logistical 
difficulties and lack of cardiology support. Three departments cited a lack of 
monitoring equipment. Nine departments did not offer this service as it was already 
provided by a nearby hospital, and one department had only 3T MRI. Five 
departments reported that they were in the process of developing a service, and 
seven cited that currently there was a lack of demand to warrant providing this 
service.  
Reported factors likely to encourage departments to start scanning included formal 
training, publication of UK guidelines, more evidence of safety, and better 
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collaboration with cardiology colleagues (although 79% of these hospitals do have 




This first survey of MRI provision for patients with CIEDs shows that despite the 
widespread availability of MR-conditional devices and increasing evidence of non 
MR-conditional device safety, less than half of MRI departments in England offer 
scans to this patient group, and overall number of patients scanned remains 
extremely low.  With increasing rates of device implantation and broadening MRI 
indications, there is a clear need to recognise and address barriers.   
Being able to perform MRI on patients with CIED is important. Approximately one in 
fifty people over the age of 75 have a CIED, with over 40,000 new devices implanted 
per year in England alone.(2,6) Given that nearly one in five of those patients with 
new devices will need an MRI scan within the first 12 months,(3) 7000 patients with 
new devices should be undergoing CMR scans per year based on current figures 
(17% of 40,000); a factor of 7 greater than are currently being performed, and this 
calculation ignores all those with existing devices who may also need scans.   
Currently less than one in two MRI departments in England provide scanning for 
patients with MR-conditional CIEDs, and just one in 28 departments for those with 
non MR-conditional CIEDs. The barriers appear multiple. Part of it appears to be 
demand: there is a lack of awareness amongst radiology, cardiology and referring 
physicians concerning the potential for MR in patients with MR-conditional CIEDs. It 
is likely that this lack of awareness is meaning patients are receiving sub-optimal 
imaging and therefore suboptimal healthcare with potential detrimental sequelae.  
Increased education and guidelines directed at a wider medical population are 
needed to increase referrals and to stimulate imaging departments to develop the 
infrastructure with which to provide MRI services to patients with MR-conditional 
devices.  A more collaborative, possibly nationally planned approach seems needed 
and may facilitate service development – including available guidelines and template 
protocols for local adaptation. We would advocate improved interaction between 
radiology and cardiology departments – without the cooperation of both parties, it 
seems unlikely that the current underprovision of services will be addressed. 
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Despite the modifications that have been made to render CIEDs MR-conditional, 
scanning still requires adherence to strict protocols, precautionary measures and 
planning, Table 2. Meeting these criteria requires coordination between radiology 
and cardiology services and local champions. A lack of cardiology support was the 
most frequently cited reason for not scanning, although the majority of departments 
had a local cardiology service and/or pacing clinic onsite. A more collaborative, 
possibly nationally planned approach seems needed and may facilitate service 
development – including available guidelines and template protocols for local 
adaptation. There may be limited capital costs needed also - 15% of departments 
reported not using either ECG or oximetry monitoring while scanning when this is 
required.  
For non MR-conditional CIED scanning, data to support ‘off label’ MRI is growing. 
The harmful effects of MRI seen in the early reports were frequently due to scans 
being performed without knowledge of the presence of a device. Summarised data 
from 14 studies (800 pacemaker patients), and 11 studies (300 ICDs) scanned at 1.5T 
had no major adverse events reported.(1) The MagnaSafe registry 
(http://www.magnasafe.org) is the largest study assessing the safety of non-thoracic 
MRI scanning in pacemaker and ICD patients (with non MR-conditional devices).(4) 
Preliminary findings based on 1500 studies, performed in 19 different US centres, 
demonstrate no deaths, loss of capture or ventricular arrhythmias during non-
thoracic MRI at 1.5T. Potentially clinically relevant change in device parameters 
(changes to lead impedance, sensitivity and thresholds, or battery voltages) were 
however seen in 12% of pacemaker patients and 29% of ICD patients, although no 
clinically-significant durable device parameter changes were noted.(7) ESC guidelines 
suggest that in patients with conventional cardiac devices, MR at 1.5 T can be 
performed with a low risk of complications if appropriate precautions are taken 
(class IIb indication).(5) We would recommend that careful consideration should be 
given as to whether the benefit of MRI scanning is deemed to outweigh the potential 
risk on an individual patient basis, and that each case is discussed between the 
cardiologist, radiologist and referring clinician.  We would advocate clear 
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documentation of written informed patient consent to scanning, to ensure that 
patients are made aware of the (albeit small) potential risks.  Additional safety 
measures are also recommended for scanning all cardiac devices (both MR 
conditional and non-MR conditional) including having a cardiologist or cardiac 
physiologist available to reprogramme the device, an external defibrillator with 
transcutaneous pacing available within the department and continuous monitoring 
throughout the scan. 
There have previously been concerns regarding degradation of image quality 
(particularly of thoracic and cardiac MRI scans) from artefacts arising from the device 
generator and leads, thereby limiting the diagnostic quality of studies.  Recent 
published evidence and anecdotal experience suggest that image quality is generally 
diagnostic, even in cardiac MR imaging, in almost all cases (Figure 4).(8,9)  
The generalizability of the results of this survey to other countries and healthcare 
systems is difficult to predict as no data has previously been published.  However, 
the response rate to this survey is significantly higher than is usually expected from 
such surveys (86% of hospitals approached provided responses, representing 97% of 
acute NHS Trusts in England).  We can therefore be confident that these results 
illustrate contemporary practice in NHS hospitals. Published data on CIED 
implantation rates suggest that England lags behind the US and other European 
countries (2), and patients are also less likely to undergo MRI scanning in general. In 
addition, NHS-funded secondary care in England is generally provided via general 
hospitals in which most specialities, including MRI and cardiology, are co-located.  
Recently published epidemiological data from the US has found that MRI utilization 
is lower in ICD patients compared to non-implant patients, despite similar co-
morbidities – one in 25 ICD patients would have qualified for imaging for a recorded 
stroke/TIA, yet less than 1% received an MRI for this indication.(10) Together this 
suggests that the problem of access to MRI scans in CIED patients is likely to be 
similarly shared by other countries and healthcare systems.    
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CONCLUSION 
This is the first report of the national provision of MRI scanning for patients with 
implanted cardiac devices. Overall less than half (46%) of MRI departments in 
England currently offer a service for patients with MR-conditional CIED’s, and only 
4% of departments will scan patients with non MR-conditional devices, despite 
extremely low reported complication rates.  Given the rising numbers of patients 
with implantable cardiac devices and the increasing clinical need for MRI scans, 
there appears to be both under-referral and under-provision of MRI services for this 
patient population.  Cross-discipline education and collaboration may hold to key to 
opening up provision of MRI services to patients with CIEDs, however the 
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Table 1 Complications reported by MRI units scanning patients with implantable 
cardiac devices 
* Reported complication from MR imaging in a patient with a non-MR conditional 
device. 
Reported complications from hospitals offering MRI scanning to 
patients with cardiac implantable electronic devices  
N (%) 
None 82 (92%) 
Minor Complications  
(e.g. Device parameters altered and re-programming required) 
5 (6%) 
Serious Complications  
(e.g. Arrhythmias, pacemaker malfunction requiring replacement) 
1* (1%) 
Not specified 1 (1%) 
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Table 2. Considerations when imaging patients with MR-conditional cardiac 
implantable electronic devices using MRI (based on published guidance and 
literature)(5,11,12) 
Before the scan 
Can the clinical information be obtained using a different imaging modality? 
Is the scanner 1.5T with maximum gradient slew rate <=200 T/ms-1? 
Are the generator and all leads confirmed to be part of a (manufacturer-specific) MR 
conditional system? 
Has the device been implanted for > 6 weeks on the date of the scan? 
Is the device located pectorally (no abdominal systems)? 
Are all leads intact? No fractured, capped or abandoned leads, adaptors or devices? 
Are lead/device parameters within limits and with adequate safety margins? 
 battery not approaching end of life 
 sensitivity, impedance and threshold of all leads within normal limits 
Is there an external defibrillator with transcutaneous pacing capability available in the MRI 
suite, and are staff trained to use it? 
Is there a suitably trained cardiac physiologist / cardiologist available to program the device 
to enable MR scanning? 
Is the device programmed to MRI safe mode?  
During the scan 
Are all MR protocols run in ‘Normal’ mode (SAR ≤ 2.0 W/kg; head SAR ≤ 3.2W/kg)? 
Is the patient being continuously monitored by at least one of ECG, BP or pulse oximetry? 
After the scan 
Has the cardiologist / physiologist checked the device parameters and reprogrammed the 
device to normal pacing mode? 
 
Additional considerations for patients with non-MR conditional devices 
Have all alternative imaging modalities been considered? 
Has the referring clinician stated in writing that the information will materially change 
management/outcome/ quality of life to outweigh the risk and discussed this with the 
patient’s cardiologist? 
Has the patient consented in writing with the uncertainty of risk communicated? 
Pre-MRI device interrogation and programming: 
 Non-pacing dependent patients should be programmed to non-tracking/ non-
pacing mode (OOO) if available, or otherwise inhibited mode (VVI/ DDI). 
 Pacemaker dependent patients should be switched to asynchronous mode (VOO/ 
DOO), with maximum output settings. 
 All anti-tachycardia/ shock therapies should be programmed off for ICD patients.  
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FIGURE LEGENDS  
Figure 1: Number of MRI scans performed in patients with MR-conditional CIEDs 
per hospital in the preceding 12 months. 
Figure 2: Reported safety precautions undertaken when scanning MRI conditional 
CIED patients (in departments who currently perform this service). 
Figure 3: Reported reasons for not scanning patients with MRI conditional CIED’s 
(from departments currently not offering the service) 
Figure 4 Example cardiac MRI images obtained in patients with MR-conditional 
pacemakers implanted on the left side. 
Panel A shows a still image from a standard short axis SSFP sequence acquired on a 
Siemens 1.5T MRI machine (Supplementary movie file 1). Artefact from the device 
generator and pacing lead within the right ventricle are visible (arrows), but do not 
limit image quality or interfere with diagnostic accuracy.  
Panel B shows a still image from a standard 4-chamber SSFP cine in a different 
patient with artefact from the RA and RV pacing leads (arrows) but no artefact from 
the generator in this image. The images obtained from this study were of sufficient 
diagnostic quality to make the diagnosis of arrhythmogenic right ventricular 
cardiomyopathy (supplementary movie file 2).  
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